MYC and lung cancer: It has been found that MAPK and NF-κB are the upstream signaling molecules of C-MYC, activation of which positively correlates with c-myc-mediated cell proliferation and cell cycle progression in lung cancer (Tang et al., 2013; Lim et al., 2016).